Join
Live feed
·
INSIDERFilingvia Quantisnow
Allogene Therapeutics Inc. logo

SEC Form 5: A Joshua Kazam gifted 305,918 units of Common Stock, decreasing ownership by 30% to 727,387 units

ByQuantisnow·Wall Street's wire, on your screen.
ALLO· Allogene Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALLO (Allogene Therapeutics Inc.) and more on Quantisnow.